ArticleCancer innovation2024

Beyond clinical trials: CDK4/6 inhibitor efficacy predictors and nomogram model from real-world evidence in metastatic breast cancer.

Binliang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.